EUVIMEDEUVIMED entdecken
Crossref

Blood‐Brain‐Barrier‐Crossing Fluorinated Luciferase Prosubstrates Enable Sensitive Monitoring of D‐Cysteine Levels in Brain Diseases

Yuexia Yang, Qian Ma, Xinyu Qiu, Zhaoming Chen, Bingbing Zheng, Hu Xiong

Angewandte Chemie · 22.06.2026 · 138 (26)

DOI: 10.1002/ange.5604948 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie, online erschienen am 05.05.2026. Verfasst von Yuexia Yang und 5 weiteren Autor:innen. Die Arbeit nennt 73 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Fundamental Research Funds for the Central Universities.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

D‐Cysteine (D‐Cys) is critically involved in regulating redox homeostasis within the brain, and its dysregulation has been closely related to the pathogenesis of various neurological disorders. However, the precise mapping of cerebral D‐Cys levels in situ remains a formidable challenge due to the lack of specific detection tools. Herein, we report a new class of fluorinated firefly luciferase prosubstrates for sensitive and noninvasive detection of D‐Cys in the brain via nitrile‐aminothiol bioorthogonal reaction. The lipophilic 7'F‐CBT exhibits enhanced blood‐brain barrier (BBB) permeability and reacts with endogenous D‐Cys to form a luciferin analog in situ, generating prolonged and intense bioluminescence. It sensitively detected D‐Cys in vitro, achieving a detection limit of 1.37 nM, and successfully imaged endogenous D‐Cys in the mouse brain with a high signal‐to‐noise ratio (60:1) after intravenous administration. Furthermore, 7'F‐CBT enabled unprecedented video‐rate visualization of D‐Cys in freely moving glioblastoma‐bearing mice. More importantly, by leveraging BBB‐permeable 7'F‐CBT , we revealed a precipitous reduction of brain D‐Cys levels in a drug‐induced Parkinson's disease (PD) mouse model for the first time. This study paves the way for diagnosing D‐Cys‐related brain diseases and provides a novel diagnostic tool.

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Fundamental Research Funds for the Central Universities
  • Nankai University

Zitieren

APA

Yang, Y., Ma, Q., Qiu, X., Chen, Z., Zheng, B., & Xiong, H. (2026). Blood‐Brain‐Barrier‐Crossing Fluorinated Luciferase Prosubstrates Enable Sensitive Monitoring of D‐Cysteine Levels in Brain Diseases. Angewandte Chemie, 138(26). https://doi.org/10.1002/ange.5604948

Vancouver

Yang Y, Ma Q, Qiu X, Chen Z, Zheng B, Xiong H. Blood‐Brain‐Barrier‐Crossing Fluorinated Luciferase Prosubstrates Enable Sensitive Monitoring of D‐Cysteine Levels in Brain Diseases. Angewandte Chemie. 2026;138(26). doi:10.1002/ange.5604948

BibTeX
@article{Yang2026,
  author = {Yang, Yuexia and Ma, Qian and Qiu, Xinyu and Chen, Zhaoming and Zheng, Bingbing and Xiong, Hu},
  title = {Blood‐Brain‐Barrier‐Crossing Fluorinated Luciferase Prosubstrates Enable Sensitive Monitoring of D‐Cysteine Levels in Brain Diseases},
  journal = {Angewandte Chemie},
  year = {2026},
  volume = {138},
  number = {26},
  doi = {10.1002/ange.5604948}
}
Kostenlos starten →